Royalty Pharma
RPRX
$27.41
Share price
3.87%
Change (1 day)
-17.37%
Change (1 year)
Categories
Royalty Pharma (RPRX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $6.26 B
According to Royalty Pharma's latest financial reports the company's total liabilities are $6.26 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Royalty Pharma - Total liabilities on balance sheet (from 2019 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $6.29 B | -13.59% |
| 2022-12-31 | $7.28 B | 0.29% |
| 2021-12-31 | $7.26 B | 18.66% |
| 2020-12-31 | $6.12 B | -2.92% |
| 2019-12-31 | $6.30 B | -7.47% |
| 2018-12-31 | $6.81 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $33.42 B | 433.32% | 🇺🇸 USA |
 Eli Lilly LLY | $51.04 B | 714.50% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.43 B | -93.02% | 🇺🇸 USA |